These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 29451838)

  • 21. Early Streptococcus pneumoniae serotype changes in Utah adults after the introduction of PCV13 in children.
    Kendall BA; Dascomb KK; Mehta RR; Stockmann C; Mason EO; Ampofo K; Pavia AT; Byington CL
    Vaccine; 2016 Jan; 34(4):474-478. PubMed ID: 26706276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence of invasive pneumococcal disease before and during an era of use of three different pneumococcal conjugate vaccines in Quebec.
    De Wals P; Lefebvre B; Deceuninck G; Longtin J
    Vaccine; 2018 Jan; 36(3):421-426. PubMed ID: 29224962
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-susceptibility trends and serotype coverage by conjugate pneumococcal vaccines in a Tunisian paediatric population: a 10-year study.
    Charfi F; Smaoui H; Kechrid A
    Vaccine; 2012 Dec; 30 Suppl 6():G18-24. PubMed ID: 23228353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines.
    Isaacman DJ; McIntosh ED; Reinert RR
    Int J Infect Dis; 2010 Mar; 14(3):e197-209. PubMed ID: 19700359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Five winters of pneumococcal serotype replacement in UK carriage following PCV introduction.
    Gladstone RA; Jefferies JM; Tocheva AS; Beard KR; Garley D; Chong WW; Bentley SD; Faust SN; Clarke SC
    Vaccine; 2015 Apr; 33(17):2015-21. PubMed ID: 25776920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of the introduction of pneumococcal conjugate vaccines on serotype prevalence in Kuwait and Saudi Arabia.
    Mokaddas EM; Shibl AM; Elgouhary A; Elsobky M
    Vaccine; 2018 Oct; 36(43):6442-6448. PubMed ID: 30194003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pneumococcal carriage and serotype variation before and after introduction of pneumococcal conjugate vaccines in patients with acute otitis media in Switzerland.
    Allemann A; Frey PM; Brugger SD; Hilty M
    Vaccine; 2017 Apr; 35(15):1946-1953. PubMed ID: 28279564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Change in Pneumococcus Serotypes but not Mortality or Morbidity in Pre- and Post-13-Valent Polysaccharide Conjugate Vaccine Era: Epidemiology in a Pediatric Intensive Care Unit over 10 Years.
    Hon KL; Chan KH; Ko PL; Cheung MHY; Tsang KYC; Chan LCN; Chan RWY; Leung TF; Ip M
    J Trop Pediatr; 2018 Oct; 64(5):403-408. PubMed ID: 29126217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of 13-valent pneumococcal conjugate vaccine against vaccine-serotype community acquired pneumococcal diseases among children in China: A test-negative case-control study.
    Xiaofei L; Yudan LI; Qinghui C; Jiaming S; Benfeng Z; Youyi Z; Biying W; Lijun Y; Jun Z; Jianmei T; Lin L; Xuejun S; Genming Z; Tao Z
    Vaccine; 2024 Feb; 42(6):1275-1282. PubMed ID: 38296700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carriage prevalence and serotype distribution of Streptococcus pneumoniae prior to 10-valent pneumococcal vaccine introduction: A population-based cross-sectional study in South Western Uganda, 2014.
    Nackers F; Cohuet S; le Polain de Waroux O; Langendorf C; Nyehangane D; Ndazima D; Nanjebe D; Karani A; Tumwesigye E; Mwanga-Amumpaire J; Scott JAG; Grais RF
    Vaccine; 2017 Sep; 35(39):5271-5277. PubMed ID: 28784282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Population structure of Streptococcus pneumoniae colonizing children before and after universal use of pneumococcal conjugate vaccines in Brazil: emergence and expansion of the MDR serotype 6C-CC386 lineage.
    Neves FPG; Cardoso NT; Souza ARV; Snyder RE; Marlow MM; Pinto TCA; Teixeira LM; Riley LW
    J Antimicrob Chemother; 2018 May; 73(5):1206-1212. PubMed ID: 29401243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nasopharyngeal carriage of Streptococcus pneumoniae serotypes among children in India prior to the introduction of pneumococcal conjugate vaccines: a cross-sectional study.
    Sutcliffe CG; Shet A; Varghese R; Veeraraghavan B; Manoharan A; Wahl B; Chandy S; Sternal J; Khan R; Singh RK; Santosham M; Arora NK
    BMC Infect Dis; 2019 Jul; 19(1):605. PubMed ID: 31291902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of PCV10 and PCV13 on pneumococcal serotype 6C disease, carriage, and antimicrobial resistance.
    Grant LR; Hanquet G; Sepúlveda-Pachón IT; Theilacker C; Baay M; Slack MPE; Jodar L; Gessner BD
    Vaccine; 2024 Apr; 42(12):2983-2993. PubMed ID: 38553292
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serotype distribution and antibiotic resistance among invasive Streptococcus pneumoniae from Oman post 13-valent vaccine introduction.
    Al-Jardani A; Al Rashdi A; Al Jaaidi A; Al Bulushi M; Al Mahrouqi S; Al-Abri S; Al-Maani A; Kumar R
    Int J Infect Dis; 2019 Aug; 85():135-140. PubMed ID: 31150842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serotype distribution and antibiotic resistance of Streptococcus pneumoniae isolates from 17 Chinese cities from 2011 to 2016.
    Zhao C; Li Z; Zhang F; Zhang X; Ji P; Zeng J; Hu B; Hu Z; Liao K; Sun H; Zhang R; Cao B; Zhuo C; Jia W; Mei Y; Chu Y; Xu X; Yang Q; Jin Y; Fu Q; Xu X; Li H; Wang L; Ni Y; Liang H; Wang H
    BMC Infect Dis; 2017 Dec; 17(1):804. PubMed ID: 29284419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Streptococcus pneumoniae as cause of acute otitis media (AOM) in Slovak children in the pneumococcal conjugate vaccine era (2008-2019).
    Macaj M; Perdochova L; Jakubikova J
    Vaccine; 2023 Jan; 41(2):452-459. PubMed ID: 36470684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serotype evolution in Western Europe: perspectives on invasive pneumococcal diseases (IPD).
    Tin Tin Htar M; Morato Martínez J; Theilacker C; Schmitt HJ; Swerdlow D
    Expert Rev Vaccines; 2019 Nov; 18(11):1145-1155. PubMed ID: 31682762
    [No Abstract]   [Full Text] [Related]  

  • 38. Serotypes and clones causing invasive pneumococcal disease before the use of new conjugate vaccines in Catalonia, Spain.
    Muñoz-Almagro C; Ciruela P; Esteva C; Marco F; Navarro M; Bartolome R; Sauca G; Gallés C; Morta M; Ballester F; Raga X; Selva L;
    J Infect; 2011 Aug; 63(2):151-62. PubMed ID: 21679725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of the pneumococcal conjugate vaccine on serotype distribution and susceptibility trends of pediatric non-invasive Streptococcus pneumoniae isolates in Tokai, Japan over a 5-year period.
    Okade H; Funatsu T; Eto M; Furuya Y; Mizunaga S; Nomura N; Mitsuyama J; Yamagishi Y; Mikamo H
    J Infect Chemother; 2014 Jul; 20(7):423-8. PubMed ID: 24802765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Invasive pneumococcal infections in Vellore, India: clinical characteristics and distribution of serotypes.
    Molander V; Elisson C; Balaji V; Backhaus E; John J; Vargheese R; Jayaraman R; Andersson R
    BMC Infect Dis; 2013 Nov; 13():532. PubMed ID: 24206667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.